Novo Nordisk Earnings: Wegovy Supply & Obesity Pipeline in Focus |
Equity Research & Insights |
Karen Andersen, CFA |
08/08/24 |
Healthcare Companies Are Going Bust. Should I be Worried? |
Equity Research & Insights |
Christopher Johnson |
06/06/24 |
Should You Invest in the Vaccine Makers? |
Equity Research & Insights |
Rentsje de Gruyter |
19/01/21 |
3 Themes for Private Equity |
Investment Trust Research & Insights |
Annalisa Esposito |
01/12/20 |
"My Healthcare Stocks Soared 700%" |
Investor Views |
Emma Simon |
16/09/20 |
Can Healthcare Stocks Keep Climbing? |
Equity Research & Insights |
Holly Black |
16/07/20 |
"Healthcare Stocks are Overpriced" |
Equity Research & Insights |
Holly Black |
26/05/20 |
Best and Worst Performing Thematic ETFs |
ETF Investing Ideas & News |
Kenneth Lamont |
18/05/20 |
How Healthcare Funds Performed in the Covid-19 Crisis |
Fund Research & Insights |
Annalisa Esposito |
31/03/20 |
Will Coronavirus Trigger a Global Recession? |
Economic Insights |
Karen Andersen |
10/03/20 |
3 Healthcare Stock Picks |
Equity Research & Insights |
Holly Black |
14/01/20 |
Outlook 2020: A US Election Won't Derail Healthcare Stocks |
Investment Trust Research & Insights |
Holly Black |
07/01/20 |
Ignore Politics, Innovation is Driving Healthcare Stocks |
Fund Research & Insights |
James Gard |
24/09/19 |
5 European Stocks With Economic Moats |
Equity Research & Insights |
David Brenchley |
02/05/19 |
The Problem With Buy and Hold |
Fund Research & Insights |
David Brenchley |
25/04/19 |
Top Asian Healthcare Stocks |
Perspectives |
External Writer |
09/04/19 |
Where US Fund Managers are Seeing Value |
Equity Research & Insights |
David Brenchley |
08/03/19 |
China A-Shares Set for MSCI Inclusion Boost |
Market Update |
David Brenchley |
01/03/19 |
GlaxoSmithKline Still Undervalued, say Analysts |
Equity Research & Insights |
Damien Conover |
08/02/19 |
Healthy Consumers Force Drinks Firms to Adapt |
Equity Research & Insights |
Holly Black |
05/02/19 |
Can Healthcare Stocks Continue their 2018 Rally? |
Equity Research & Insights |
David Brenchley |
30/01/19 |
Why Now is the Time to Invest in Infrastructure |
Market Update |
David Brenchley |
11/01/19 |
3 Stock Picks for the New Year |
Equity Research & Insights |
Emma Wall |
09/01/19 |
Ethical Funds for a Greener Christmas |
Fund Research & Insights |
Holly Black |
24/12/18 |
Healthcare Stocks Aren't Cheap But Offer Attractive Returns |
Equity Research & Insights |
Philip Straehl |
22/11/18 |
5 Best and Worst Top-Rated Trusts in Q3 |
Investment Trust Research & Insights |
David Brenchley |
04/10/18 |
Henderson Backs Two Tech Alternative Trusts |
Investment Trust Research & Insights |
David Brenchley |
25/09/18 |
Hobson: I'm Wary of Spire but Upbeat on Kier |
The Week |
Rodney Hobson |
21/09/18 |
Healthcare: Profit from an Ageing Population |
Market Update |
Emma Wall |
17/09/18 |
ETF Investors Look to Healthcare Stocks |
ETF Research & Insights |
David Brenchley |
13/09/18 |
5 Global Stocks for Income Investors |
Equity Research & Insights |
David Brenchley |
04/09/18 |
5 Best Investment Trusts of 2018 |
Investment Trust Research & Insights |
David Brenchley |
20/07/18 |
Look Beyond Dividends to Total Payouts |
Equity Research & Insights |
Dan Kemp |
16/05/18 |
Reckitt Benckiser Shares Still Undervalued |
Equity Research & Insights |
Philip Gorham |
24/04/18 |
Woodford-Backed Prothena Loses 70% |
Equity Research & Insights |
David Brenchley |
24/04/18 |
Shire Stock Undervalued Despite Takeover Bid |
Equity Research & Insights |
Karen Andersen, CFA |
20/04/18 |
Finding Property Income Despite Brexit |
Fund Research & Insights |
Emma Wall |
05/03/18 |
Killik's 3 Stock Picks for February |
Equity Research & Insights |
Emma Wall |
07/02/18 |
Which Investment Factors Drove Market Returns in 2017? |
Equity Research & Insights |
Morningstar News Team |
24/01/18 |
IMF Too Upbeat on Global Growth, says Carmignac |
Economic Insights |
David Brenchley |
24/01/18 |
Best Performing FTSE 100 Stocks of 2017 |
Equity Research & Insights |
David Brenchley |
19/12/17 |
Will the Budget Boost Woodford's Performance? |
Investment Trust Research & Insights |
David Brenchley |
01/12/17 |
Invesco's Mark Barnett: Why I'm Investing in Oil |
Equity Research & Insights |
David Brenchley |
14/11/17 |
Woodford on: Lloyds, Barclays, RBS, Astra and Glaxo |
Equity Research & Insights |
David Brenchley |
10/11/17 |
Revealed: The Funds Hit by AstraZeneca Slump |
Fund Research & Insights |
Karen Kwok |
27/07/17 |
Pfizer Offers Dividend Opportunity |
Equity Research & Insights |
Damien Conover, CFA |
07/06/17 |
Biotech Trusts Trade at Discount |
Investment Trust Research & Insights |
Karen Kwok |
26/05/17 |
US Healthcare Policy Will Have "Minimum Impact" on Stocks |
Equity Research & Insights |
Karen Kwok |
18/05/17 |
Are Healthcare Stocks Too Expensive? |
Equity Research & Insights |
Dan Kemp |
02/05/17 |
Market Outlook: Healthcare Stocks |
Equity Research & Insights |
Damien Conover, CFA |
13/04/17 |